ISPOR 2023

As stakeholder engagement becomes increasingly science-based and evidence-driven, generating actionable evidence – especially RWE and HEOR data – in a timely manner has become more important than ever. Further, the ability to anticipate, shape, and optimize product development has become one of the most critical success factors for realizing an innovation’s full promise. 

Syneos Health will be joining thousands of healthcare leaders at ISPOR’s global event on key health economics and outcomes research (HEOR) topics.

Our team of experts will be on the floor at ISPOR 2023 to discuss RWE and HEOR strategies that can optimize your asset’s value story, and lead to greater clinical and commercial success and improved patient outcomes. 

Find us at Booth #1241 or schedule a meeting to discuss your pressing evidence challenges.

Book a Meeting

FEATURED RESEARCH POSTERS:

• Identification of Patients Diagnosed with Rare and Emerging Diseases Utilizing the Trinetx Network: A Case Study of African and American Trypanosomiasis **AVAILABLE TO VIEW MAY 8**
• Patient‑Reported Outcomes to Support Regulation, Reimbursement and Health Policy Among Patients with Head and Neck Cancers: A Systematic Review **AVAILABLE TO VIEW MAY 8**
• Characteristics of Patients treated with CAR-T therapies across multiple indications using the TriNetX Network **AVAILABLE TO VIEW MAY 8**
• Diagnoses of Long COVID in the United States: Analysis of a Large Claims Database **AVAILABLE TO VIEW MAY 9**
• Time to approval for Chimeric Antigen Receptor T-cells (CAR-T) therapies among Nordic Countries **AVAILABLE TO VIEW MAY 9**
• Identification of Patients Diagnosed with Rare and Emerging Diseases Utilizing Real-World Claims Data - A Case Study of African and American Trypanosomiasis **AVAILABLE TO VIEW MAY 10**

Additional Resources

詳細に興味がおありですか？Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below: 

Capabilities
サイネオス・ヘルス メディカルアフェアーズ

Real World and Late Phase at Syneos Health

HEOR（医療経済と治療実績調査）

インサイト
ウェビナー：統合されたエビデンス生成を通じてバリューストーリーを最適化

資産開発のためのRWE、RWD、トークン化：バイオ医薬品チームが知っておくべきこと

オンコロジーにおけるリアルワールドエビデンスのためのマーケットアクセスケースの作成

Success Factors in Long-Term Follow-Up Studies

Amplifying the Synergy Between Medical Affairs and Clinical Development

サイネオス・ヘルスのポッドキャスト：Medical Affairs Series

Syneos Health Podcast: The Value of Registries  

BOOK A MEETING